Novel Systemic Therapies in the Management of Tyrosine Kinase Inhibitor-Pretreated Patients with Epidermal Growth Factor Receptor-Mutant Non-Small-cell Lung Cancer
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY（2023）
Key words
EGFR,non-small-cell lung cancer,novel systemic therapy,pretreatment,targeted therapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined